Stock Price Quote

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises
BSE1362.602.45 (+0.18 %)
PREV CLOSE ( ) 1360.15
OPEN PRICE ( ) 1353.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2104
TODAY'S LOW / HIGH ( )1345.05 1375.00
52 WK LOW / HIGH ( )645.7 1529.95
NSE1365.456.2 (+0.46 %)
PREV CLOSE( ) 1359.25
OPEN PRICE ( ) 1354.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16438
TODAY'S LOW / HIGH( ) 1345.70 1380.00
52 WK LOW / HIGH ( )645.5 1505
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2007
Management Info
Harsh Goenka - Chairman Yugal Sikri - Managing Director
Registered Office

Address R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022 - 24981650 / 24986375

Email info@rpglifesciences.com

Website www.rpglifesciences.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

19Oct RPG Life Sciences to execute power del
RPG Life Sciences has received approval for execution of Power Delivery..
19Oct RPG Life Sciences gains on geting nod
RPG Life Sciences is currently trading at Rs. 1426.00, up by 19.60 point..
19Oct RPG Life Sciences informs about invest
RPG Life Sciences has informed that it enclosed a copy of Investor Prese..
16Oct Rpg Life Sciences informs about loss o
Rpg Life Sciences has informed that it enclosed intimation of loss of sh..
11Oct RPG Life Sciences informs about certif
RPG Life Sciences has informed that it enclosed certificate dated Octobe..

Financials

in Millions
QTR Sep 23 ANNUAL 23
Net Profit258.6676.400000000001
Gross Profit 347.9 916.800000000001
Operating Profit 391.21074.9
Net Sales 1535.85128.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  4884.60 (3.27%)
M.Cap ( in Cr)58402.72
Dr. Reddy's Lab (BSE)
peergroup  5784.05 (0.98%)
M.Cap ( in Cr)96478.08
Astrazeneca Pharma I (BSE)
peergroup  4855.10 (0.95%)
M.Cap ( in Cr)12137.75
Mankind Pharma (BSE)
peergroup  1997.90 (2.33%)
M.Cap ( in Cr)80033.56
TTK Healthcare (BSE)
peergroup  1389.95 (3.27%)
M.Cap ( in Cr)1964.05

Shareholding Pattern

PROMOTERS 72.81%
NON-INSTITUTION 25.16%
MUTUAL FUNDS/UTI 0.82%
FI/BANKS/INSURANCE 0.52%
GOVERNMENT 0%
FII 0%

About RPG Life Sciences Ltd.

RPG Life Sciences Ltd. was incorporated in the year 2007. Its today's share price is 1362.6. Its current market capitalisation stands at Rs 2253.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5547.7 Cr and Total Income of Rs.5176.1 Cr. The company's management includes Rajat Bhargava, Sachin Nandgaonkar, Bhaskar Iyer, Zahabiya Khorakiwala, Narendra Ambwani, Manoj K Maheshwari, Lalit S Kanodia, Mahesh S Gupta, Yugal Sikri, Harsh Goenka, Rajesh Shirambekar.

It is listed on the BSE with a BSE Code of 532983 , NSE with an NSE Symbol of RPGLIFE and ISIN of INE105J01010. It's Registered office is at R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Lovelock & Lewes, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.